MAPK1 and neoplasm: In CRC, constitutive activation of the MAPK/ERK signaling axis has been mechanistically linked to multiple malignant phenotypes, including sustained tumor proliferation, metastatic dissemination, and the development of therapeutic resistance [47, 48].